Zura Bio Limited Class A Ordinary Shares earnings per share and revenue
On 13 de nov. de 2025, ZURA reported earnings of -0.21 USD per share (EPS) for Q3 25, missing the estimate of -0.18 USD, resulting in a -13.45% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -9.72% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analistas forecast an EPS of -0.20 USD, with revenue projected to reach -- USD, implying an diminuir of -4.76% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were Zura Bio Limited Class A Ordinary Shares's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Zura Bio Limited Class A Ordinary Shares reported EPS of -$0.21, missing estimates by -13.45%, and revenue of $0.00, 0% as expectations.
How did the market react to Zura Bio Limited Class A Ordinary Shares's Q3 2025 earnings?
The stock price moved down -9.72%, changed from $4.63 before the earnings release to $4.18 the day after.
When is Zura Bio Limited Class A Ordinary Shares expected to report next?
The next earning report is scheduled for 23 de mar. de 2026.
What are the forecasts for Zura Bio Limited Class A Ordinary Shares's next earnings report?
Based on 9
analistas, Zura Bio Limited Class A Ordinary Shares is expected to report EPS of -$0.20 and revenue of -- for Q4 2025.